We are live on
!
Find out more
JCM
JD Capital Management Portfolio holdings
AUM
$232M
1-Year Est. Return
54.6%
This Fund
S&P 500
This Quarter
Est. Return
+0.68%
1 Year Est. Return
+54.6%
3 Year Est. Return
+47.78%
5 Year Est. Return
+201.56%
10 Year Est. Return
–
AUM
$347M
AUM Growth
-$66.1M
(-16%)
Cap. Flow
-$46.8M
Cap. Flow
% of AUM
-13.47%
Top 10 Holdings %
Top 10 Hldgs %
96.5%
Holding
27
New
1
Increased
4
Reduced
4
Closed
11
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MON
Monsanto Co
MON
|
+$20M |
| 2 |
Meta Platforms (Facebook)
META
|
+$11M |
| 3 |
CELG
Celgene Corp
CELG
|
+$11M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$11M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 1.38% |
| 2 | Communication Services | 0% |
| 3 | Consumer Discretionary | 0% |
| 4 | Financials | 0% |
| 5 | Healthcare | 0% |
Similar funds
CCM
EA
BG
PVWM
BRC
MCFIG
PWAP
BWI
JD Capital Management's Q3 2017 Portfolio in Review
As of Q3 2017, JD Capital Management held 27 positions worth $347M, down 16% from $413M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
JD Capital Management withdrew a net $46.8M in Q3 2017, closing 11 positions and reducing 4 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $11M position sold in full.
By sector, the portfolio is most concentrated in Materials at 1.4% of assets, down from 6% a quarter earlier, followed by Communication Services and Consumer Discretionary.
- JD Capital Management's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $20M.
- JD Capital Management fully exited Meta Platforms (Facebook) in Q3 2017, selling an estimated $11M.
- JD Capital Management's ten largest holdings make up 97% of its $347M portfolio in Q3 2017.
- JD Capital Management opened 1 new position and closed 11 in Q3 2017.
- JD Capital Management's portfolio value fell 16% quarter-over-quarter to $347M.
Based on JD Capital Management's 13F filing for Q3 2017, filed 13 Nov 2017.